ANIX vs. MTZ

Last updated Apr 1, 2026

Compare and contrast key facts about Anixa Biosciences, Inc. (ANIX) and MasTec, Inc. (MTZ).

Performance

ANIX vs. MTZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Anixa Biosciences, Inc. (ANIX) and MasTec, Inc. (MTZ). The values are adjusted to include any dividend payments, if applicable.

ANIX vs. MTZ - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ANIX Anixa Biosciences, Inc.	-17.31%	34.48%	-40.21%	-8.71%	43.10%	-3.26%	-6.40%	-16.75%	66.95%	-56.30%
MTZ MasTec, Inc.	48.01%	59.67%	79.79%	-11.26%	-7.53%	35.35%	6.27%	58.19%	-17.14%	27.97%

Fundamentals

Market Cap ANIX : $85.76M MTZ : $25.33B
EPS ANIX : -$0.24 MTZ : $5.06
PB Ratio ANIX : 5.69 MTZ : 7.60
Total Revenue (TTM) ANIX : $0.00 MTZ : $14.30B
Gross Profit (TTM) ANIX : -$9.00K MTZ : $1.79B
EBITDA (TTM) ANIX : -$11.03M MTZ : $1.10B

Returns By Period

In the year-to-date period, ANIX achieves a -17.31% return, which is significantly lower than MTZ's 48.01% return. Over the past 10 years, ANIX has underperformed MTZ with an annualized return of -1.32%, while MTZ has yielded a comparatively higher 31.86% annualized return.

ANIX

• 1D: 3.20%
• 1M: -13.42%
• YTD: -17.31%
• 6M: -21.82%
• 1Y: -9.79%
• 3Y*: -15.66%
• 5Y*: -11.49%
• 10Y*: -1.32%

MTZ

• 1D: 5.21%
• 1M: 7.96%
• YTD: 48.01%
• 6M: 51.19%
• 1Y: 175.67%
• 3Y*: 50.47%
• 5Y*: 27.69%
• 10Y*: 31.86%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ANIX vs. MTZ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ANIX

ANIX Risk / Return Rank: 36
ANIX Sharpe Ratio Rank: 35
ANIX Sortino Ratio Rank: 39
ANIX Omega Ratio Rank: 38
ANIX Calmar Ratio Rank: 33
ANIX Martin Ratio Rank: 33

MTZ

MTZ Risk / Return Rank: 98
MTZ Sharpe Ratio Rank: 99
MTZ Sortino Ratio Rank: 97
MTZ Omega Ratio Rank: 97
MTZ Calmar Ratio Rank: 99
MTZ Martin Ratio Rank: 99

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ANIX vs. MTZ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Anixa Biosciences, Inc. (ANIX) and MasTec, Inc. (MTZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ANIX	MTZ	Difference
Sharpe ratio Return per unit of total volatility	-0.13	4.32	-4.45
Sortino ratio Return per unit of downside risk	0.39	4.22	-3.83
Omega ratio Gain probability vs. loss probability	1.05	1.61	-0.56
Calmar ratio Return relative to maximum drawdown	-0.25	12.68	-12.93
Martin ratio Return relative to average drawdown	-0.52	37.92	-38.44
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ANIX vs. MTZ - Sharpe Ratio Comparison

The current ANIX Sharpe Ratio is -0.13, which is lower than the MTZ Sharpe Ratio of 4.32. The chart below compares the historical Sharpe Ratios of ANIX and MTZ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ANIX	MTZ	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.13	4.32	-4.45
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.16	0.66	-0.82
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.01	0.73	-0.75
Sharpe Ratio (All Time) Calculated using the full available price history	-0.07	0.19	-0.26

Correlation

The correlation between ANIX and MTZ is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ANIX vs. MTZ - Dividend Comparison

Neither ANIX nor MTZ has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

ANIX vs. MTZ - Drawdown Comparison

The maximum ANIX drawdown since its inception was -98.74%, roughly equal to the maximum MTZ drawdown of -97.72%. Use the drawdown chart below to compare losses from any high point for ANIX and MTZ.

Drawdown Indicators

	ANIX	MTZ	Difference
Max Drawdown Largest peak-to-trough decline	-98.74%	-97.72%	-1.02%
Max Drawdown (1Y) Largest decline over 1 year	-52.11%	-14.13%	-37.98%
Max Drawdown (5Y) Largest decline over 5 years	-65.37%	-61.01%	-4.36%
Max Drawdown (10Y) Largest decline over 10 years	-91.11%	-67.92%	-23.19%
Current Drawdown Current decline from peak	-94.57%	-0.56%	-94.01%
Average Drawdown Average peak-to-trough decline	-77.25%	-52.14%	-25.11%
Ulcer Index Depth and duration of drawdowns from previous peaks	25.30%	4.72%	+20.58%

Volatility

ANIX vs. MTZ - Volatility Comparison

The current volatility for Anixa Biosciences, Inc. (ANIX) is 12.26%, while MasTec, Inc. (MTZ) has a volatility of 14.12%. This indicates that ANIX experiences smaller price fluctuations and is considered to be less risky than MTZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ANIX	MTZ	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.26%	14.12%	-1.86%
Volatility (6M) Calculated over the trailing 6-month period	58.83%	29.41%	+29.42%
Volatility (1Y) Calculated over the trailing 1-year period	76.17%	40.95%	+35.22%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	71.71%	42.17%	+29.54%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	93.50%	43.63%	+49.87%

Financials